(2024) Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia:a target trial emulation of 1685 episodes. The Lancet regional health. Western Pacific. 101226. ISSN 2666-6065
Abstract
BACKGROUND: Prompt antibiotic administration for febrile neutropenia (FN) is standard of care, and targets of time to antibiotics (TTA) <60 min are common. We sought to determine the effect of TTA ≥60 versus <60 min on adverse outcomes (intensive care unit (ICU) admission or death) in children with cancer and FN. Effect modification by a decision rule that predicts infection (AUS-rule) and bacteraemia were also investigated. METHODS: The prospective, multi-centre (n = 8), Australian PICNICC study dataset was analysed. To control for confounding, we used outcome regression adjusted for propensity score modelled as restricted cubic spline with two degrees of freedom. The propensity score was estimated from a logistic regression model for the exposure on the confounders, identified a priori (age, sex, severely unwell, disease, chemotherapy intensity and site). TTA was defined as time from from emergency triage to first antibiotic dose. FINDINGS: 1685 FN episodes in 976 patients were included. Median TTA was 53 min (IQR 37-77 min, 1542 (92%) <120 min). An adverse outcome occurred in 43 (2.6%) episodes (39 ICU; 5 deaths). The confounder-adjusted point estimate suggested a lower risk for adverse outcome associated with TTA ≥60 min (RR 0.62, 95% CI 0.32-1.21), but the wide 95% CI precluded definitive judgement about strength and direction of the effect (unadjusted RR 0.52; 95% CI 0.26, 1.05). Similarly, although the point estimates were suggestive of a null association or reduced risk for adverse outcome associated with TTA ≥60 min for all comparisons across bacteraemia or AUS-rule strata, the 95% CIs were imprecise. INTERPRETATION: For children with FN, there was no definite evidence that TTA ≥60 min from hospital triage (but within 2 h), increased risk of adverse outcome or prolonged hospital admission. This study has important implications for FN TTA mandates, suggesting a more nuanced approach is required. FUNDING: National Health and Medical Research Council and Medical Research Future Fund.
Metadata
Item Type: | Article |
---|---|
Copyright, Publisher and Additional Information: | © 2024 The Author(s). |
Dates: |
|
Institution: | The University of York |
Academic Units: | The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York) The University of York > Faculty of Sciences (York) > Hull York Medical School (York) |
Depositing User: | Pure (York) |
Date Deposited: | 27 Nov 2024 08:50 |
Last Modified: | 01 Dec 2024 04:00 |
Published Version: | https://doi.org/10.1016/j.lanwpc.2024.101226 |
Status: | Published |
Refereed: | Yes |
Identification Number: | 10.1016/j.lanwpc.2024.101226 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:220147 |
Download
Filename: 1-s2.0-S2666606524002207-main.pdf
Description: Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodes
Licence: CC-BY-NC 2.5